AARTIPHARMPharmaceuticals
Aarti Pharmalabs Ltd — PE Ratio & Valuation Analysis
₹591.95
-4.72%
Current P/E26.57xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E25.8x3.1% above avg
✅
16.4% Discount to Industry
AARTIPHARM P/E 26.57x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹30.04 | ₹752 | 25x |
| 2024 | ₹23.93 | ₹686 | 28.7x |
| 2023 | ₹21.35 | ₹504 | 23.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Aarti Pharmalabs Ltd Valuation
Aarti Pharmalabs Ltd (AARTIPHARM) currently trades at 26.57x earnings. The Pharmaceuticals sector average PE is 31.77x. AARTIPHARM is trading at a discount to peers — may indicate relative value. Historically, AARTIPHARM has traded at an average PE of 25.8x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
14.54%
Dividend Yield
0.71%
More on Aarti Pharmalabs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.